3 ms·
Seems like the problem is broadly in the medical sector (including pharmacological). There is 0 reasons why it would cost over $1. Maybe $2. $40 is still way ri
by csomar 8y ago
Seems like the problem is broadly in the medical sector (including pharmacological). There is 0 reasons why it would cost over $1. Maybe $2. $40 is still way ridiculous. I mean in a competitive market.
- deleted 8y ago[deleted]
- jhayward 8y agoThe problem is there will never be a truly competitive market in most health care products and services. Necessary regulation creates too many barriers to entry and competition, and the ultimate consumer has very little demand flexibility or even choice of provider. What is needed is a monopsony buyer who can negotiate in this arena on a more even footing. In other words, single-payer.